Top

Journal of Translational Medicine

Published in:

Open Access 01-12-2022 | Correction

Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Authors: Klaus J. Wirth, Carmen Scheibenbogen, Friedemann Paul

Published in: Journal of Translational Medicine | Issue 1/2022

Excerpt

Two errors were noticed after publication of the original article [1]:

Carmen Scheibenbogen should also be a corresponding author

4 references and their citations were missing [2‐5] in the Decreased cerebral blood flow (CBF) section.

…

Wirth KJ, Scheibenbogen C, Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Transl Med. 2021;19:471. https://doi.org/10.1186/s12967-021-03143-3.CrossRefPubMedPubMedCentral

Campen C, Rowe PC, Visser FC. Reductions in cerebral blood flow can be provoked by sitting in severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. Healthcare (Basel). 2020. https://doi.org/10.3390/healthcare8040394.CrossRef

van Campen C, Rowe PC, Visser FC. Cerebral blood flow is reduced in severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing. Healthcare (Basel). 2020. https://doi.org/10.3390/healthcare8020169.CrossRef

van Campen C, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. 2020;5:50–8. https://doi.org/10.1016/j.cnp.2020.01.003.CrossRefPubMed

van Campen CMC, Rowe PC, Visser FC. Cerebral blood flow remains reduced after tilt testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. Clin Neurophysiol Pract. 2021;6:245–55. https://doi.org/10.1016/j.cnp.2021.09.001.CrossRefPubMed

Title: Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Authors: Klaus J. Wirth
Carmen Scheibenbogen
Friedemann Paul
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: Journal of Translational Medicine / Issue 1/2022
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-021-03216-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Unilateral acute lung injury in pig: a promising animal model

Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA

A genetic map of the chromatin regulators to drug response in cancer cells

Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis

Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection

Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials